Medicare Enrolled

Dr. Victoria Loseva, MD

Endocrinology · Boca Raton, FL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
1500 NW 10TH AVE STE 205, Boca Raton, FL 33486
5613911085
In practice since 2012 (13 years)
NPI: 1063775674 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Loseva from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Loseva? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Loseva

Dr. Victoria Loseva is an endocrinology specialist in Boca Raton, FL, with 13 years of NPI registration. Based on federal Medicare data, Dr. Loseva performed 24,976 Medicare services across 14,247 unique beneficiaries.

Between the years covered by Open Payments, Dr. Loseva received a total of $6,771 from 42 pharmaceutical and/or device companies across 382 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Loseva is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 13 years in practice ▲ Top 3% volume in FL $6,771 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 125781 Clear January 31, 2028
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary

Medicare Utilization ↗
24,976
Medicare services
Top 3% in FL for endocrinology
14,247
Unique beneficiaries
$20
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,921 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min) 1,145 $94 $134
Blood draw (venipuncture) 1,091 $6 $7
Comprehensive metabolic blood panel 1,075 $10 $30
Lipid panel (cholesterol and triglycerides) 998 $13 $35
Ldl cholesterol level 998 $10 $30
Measurement c-reactive protein for detection of infection or inflammation, high sensitivity 994 $13 $25
Hemoglobin A1c test (diabetes monitoring) 981 $9 $25
Thyroid stimulating hormone (TSH) test 882 $16 $40
Free thyroxine (T4) test 878 $9 $20
Thyroglobulin (thyroid related hormone) level 792 $16 $35
Thyroglobulin (thyroid protein) antibody measurement 778 $16 $35
Thyroid hormone, t3 measurement, free 769 $17 $25
Vitamin D level test 724 $29 $50
Vitamin B-12 level test 719 $15 $30
Folic acid level test 716 $14 $30
Osteocalcin (bone protein) level 640 $29 $45
C-peptide (protein) level 621 $20 $35
Insulin measurement, total 619 $11 $20
Thyroxine binding globulin (thyroid related protein) level 580 $14 $25
Creatinine test (kidney function) 576 $5 $15
Urine microalbumin test (kidney screening) 564 $6 $10
Cortisol (hormone) measurement, total 564 $16 $45
Complete blood count (CBC) with differential 563 $8 $25
Urinalysis, manual 560 $3 $6
Adrenocorticotropic hormone (acth) level 555 $38 $60
Total protein level, urine 522 $4 $5
Complete blood count (CBC), automated 503 $6 $25
Microsomal antibodies (autoantibody) measurement 487 $14 $30
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report 338 $26 $37
Dehydroepiandrosterone (dhea-s) hormone level 320 $22 $35
Lipoprotein (a) level 269 $14 $25
Hospital follow-up visit, moderate complexity 266 $65 $84
Parathyroid hormone level test 236 $40 $65
Testosterone (hormone) level, total 194 $25 $49
Testosterone (hormone) level, free 186 $25 $44
Blood glucose (sugar) level 173 $4 $10
PSA test (prostate cancer screening) 168 $18 $20
Aldosterone hormone level 165 $40 $65
Sex hormone binding globulin (protein) level 159 $21 $35
Office visit, established patient (20-29 min) 134 $70 $96
Gonadotropin, follicle stimulating (reproductive hormone) level 109 $18 $45
Gonadotropin, luteinizing (reproductive hormone) level 108 $18 $45
Ultrasound scan of head and neck soft tissue 106 $81 $117
Iron binding capacity test 102 $9 $15
Ferritin level test (iron stores) 99 $13 $25
Iron level test 99 $6 $15
Somatomedin (growth factor) level 90 $21 $35
Homocysteine (amino acid) level 87 $18 $30
Analysis using chemiluminescent technique (light and chemical )reaction 85 $14 $35
Human growth hormone level 81 $16 $30
New patient office visit (45-59 min) 73 $113 $182
Calcitonin (hormone) level 71 $26 $50
Initial hospital admission, high complexity 66 $141 $187
Thyroid hormone, t3 measurement, total 58 $14 $35
Prolactin (milk producing hormone) level 55 $19 $44
Magnesium level test 35 $7 $15
Thyroid stimulating immune globulins (thyroid related protein) level 32 $50 $51
Phosphate level test 30 $5 $10
Bone density scan (DEXA) 28 $38 $40
Office visit, established patient, complex (40-54 min) 23 $133 $192
Glycated protein level 19 $16 $25
Creatine kinase (cardiac enzyme) level, total 18 $6 $15
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,771
Total received (2018-2024)
Avg $967/year across 7 years
Top 38% in FL for endocrinology
42
Companies
382
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,771 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,248
2023
$926
2022
$1,473
2021
$1,503
2020
$786
2019
$499
2018
$337

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$1,356
Lilly USA, LLC
$1,128
SANOFI-AVENTIS U.S. LLC
$835
Amgen Inc.
$452
Boehringer Ingelheim Pharmaceuticals, Inc.
$346
AbbVie, Inc.
$236
Horizon Therapeutics plc
$185
AstraZeneca Pharmaceuticals LP
$169
Amneal Pharmaceuticals LLC
$150
Amarin Pharma Inc.
$136
Xeris Pharmaceuticals, Inc.
$131
Dexcom, Inc.
$127
MannKind Corporation
$115
Bayer Healthcare Pharmaceuticals Inc.
$108
Alvogen Inc
$99
Radius Health, Inc.
$96
Becton, Dickinson and Company
$86
Merck Sharp & Dohme Corporation
$84
Mannkind Corporation
$83
Insulet Corporation
$82
Valeritas, Inc.
$65
RECORDATI_RARE_DISEASES_INC.
$58
ABBVIE INC.
$57
AbbVie Inc.
$54
Intuity Medical Inc
$52
Bayer HealthCare Pharmaceuticals Inc.
$50
Abbott Laboratories
$47
IBSA Pharma Inc.
$41
BETA BIONICS, INC.
$38
EUSA Pharma (US) LLC
$38
Ultragenyx Pharmaceutical Inc.
$36
Medtronic, Inc.
$33
Takeda Pharmaceuticals U.S.A., Inc.
$28
Alexion Pharmaceuticals, Inc.
$25
Ascendis Pharma Inc
$22
Corcept Therapeutics
$22
PFIZER INC.
$21
GRT US Holding, Inc.
$21
VistaPharm, Inc.
$17
VIVUS LLC
$17
Linus Health, Inc.
$13
Novartis Pharmaceuticals Corporation
$12
Top 3 companies account for 49.0% of total payments
Associated products mentioned in payments ›
AFREZZA · APIDRA · BAQSIMI · BD NANO · BD Nano · CORE COGNITIVE EVALUATION · Crysvita · Dexcom G6 Transmitter · EVENITY · FARXIGA · FREESTYLE LIBRE 2 · FreeStyle Libre 2 · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · ISTURISA · JANUVIA · JARDIANCE · Kerendia · Korlym · LEQVIO · MINIMED 780G · MOUNJARO · Minimed 670G System · Omnipod · Ozempic · PREVNAR 20 · Pogo Automatic Blood Glucose Monitoring System · Prolia · QSYMIA · Qutenza · RECORLEV · RYBELSUS · Repatha · Rybelsus · SOLIQUA 100/33 · STRENSIQ · SYNTHROID · Saxenda · Sylvant · Synthroid · TEPEZZA · TERIPARATIDE · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Thyquidity · Tirosint · Tymlos · UNITHROID · V-GO · Vascepa · Wegovy · iLet Bionic Pancreas
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $27 per 100 Medicare services performed
Looking for an endocrinology specialist in Boca Raton?
Compare endocrinologists in the Boca Raton area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
67
Per 100K population
4.4
County median income
$81,115
Nearest hospital
BOCA RATON REGIONAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Loseva is a mixed practice specialist, with above-average Medicare volume (top 3% in FL), with low-engagement industry engagement.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Loseva experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Loseva performed 1,145 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Loseva receive payments from pharmaceutical companies?
Yes. Dr. Loseva received a total of $6,771 from 42 companies across 382 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Loseva's costs compare to other endocrinologists in Boca Raton?
Dr. Loseva's average Medicare payment per service is $20. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Loseva) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →